Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
Nom du journal : Eur J Cancer
Année : 2023
Volume : 183
Page de départ : 24-37
